Analyzing the Interplay between COVID-19 Viral Load, Inflammatory Markers, and Lymphocyte Subpopulations on the Development of Long COVID
-
Published:2023-09-06
Issue:9
Volume:11
Page:2241
-
ISSN:2076-2607
-
Container-title:Microorganisms
-
language:en
-
Short-container-title:Microorganisms
Author:
Rivera-Cavazos Andrea12ORCID, Luviano-García José Antonio13, Garza-Silva Arnulfo12ORCID, Morales-Rodríguez Devany Paola12, Kuri-Ayache Mauricio4, Sanz-Sánchez Miguel Ángel12, Santos-Macías Juan Enrique13, Romero-Ibarguengoitia Maria Elena12, González-Cantú Arnulfo23
Affiliation:
1. Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García 66238, Nuevo León, Mexico 2. Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza 66450, Nuevo León, Mexico 3. Internal Medicine Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza 66450, Nuevo León, Mexico 4. Cardiology Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza 66450, Nuevo León, Mexico
Abstract
The global impact of the SARS-CoV-2 infection has been substantial, affecting millions of people. Long COVID, characterized by persistent or recurrent symptoms after acute infection, has been reported in over 40% of patients. Risk factors include age and female gender, and various mechanisms, including chronic inflammation and viral persistence, have been implicated in long COVID’s pathogenesis. However, there are scarce studies in which multiple inflammatory markers and viral load are analyzed simultaneously in acute infection to determine how they predict for long COVID at long-term follow-up. This study explores the association between long COVID and inflammatory markers, viral load, and lymphocyte subpopulation during acute infection in hospitalized patients to better understand the risk factors of this disease. This longitudinal retrospective study was conducted in patients hospitalized with COVID-19 in northern Mexico. Inflammatory parameters, viral load, and lymphocyte subpopulation during the acute infection phase were analyzed, and long COVID symptoms were followed up depending on severity and persistence (weekly or monthly) and assessed 1.5 years after the acute infection. This study analyzed 79 patients, among them, 41.8% presented long COVID symptoms, with fatigue being the most common (45.5%). Patients with long COVID had higher lymphocyte levels during hospitalization, and NK cell subpopulation levels were also associated with long COVID. ICU admission during acute COVID-19 was also linked to the development of long COVID symptoms.
Funder
Hospital Clinica Nova
Subject
Virology,Microbiology (medical),Microbiology
Reference42 articles.
1. World Health Organization (2023, July 03). Coronavirus Disease (COVID-19). Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. 2. Crook, H., Raza, S., Nowell, J., Young, M., and Edison, P. (2021). Long Covid—Mechanisms, Risk Factors, and Management. BMJ, 374. 3. Greenhalgh, T., Sivan, M., Delaney, B., Evans, R., and Milne, R. (2022). Long Covid—An Update for Primary Care. BMJ, 378. 4. Ziauddeen, N., Gurdasani, D., O’Hara, M.E., Hastie, C., Roderick, P., Yao, G., and Alwan, N.A. (2022). Characteristics and Impact of Long Covid: Findings from an Online Survey. PLoS ONE, 17. 5. Scharf, R.E., and Anaya, J.-M. (2023). Post-COVID Syndrome in Adults—An Overview. Viruses, 15.
|
|